Complete FDA and NHTSA recall records dated in 2026, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Medline kits contain B. Braun IV Administration Sets and Pump Administration Sets which were recalled due to customer complaints identifying that the check valve components may become stuck…
Philips has identified that in a limited number of impacted systems the drip tray beneath the cooling unit was not installed under previous field corrections, or evidence of the…
Access Port System tray may develop cracks potentially resulting in a sterility breach.
Medline kits containing Stryker's Strykeflow 2 Suction Irrigators due to a change in design in 2024, irrigation solution is able to travel to the handpiece and battery pack during use of…
There is a potential for formation of ice occurring in the venting system of the superconducting magnet of the MRI systems. if a quench occurs in this condition, helium gas may not be able…
Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field…
Foreign material
Unapproved color (carmoisine).
Undeclared Soy. Label did not include soy, which was used in product.
Undeclared Soy. Label did not include soy, which was used in product.
Unapproved color (carmoisine).
Product tested high for lead.
Potential undeclared allergen ingredient (Wheat)
undeclared hazelnut.
Undeclared Soy. Label did not include soy, which was used in product.
Product tested high for lead.
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.
